相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels
Philip S. Y. Tsang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
Manoj Kumar et al.
GASTROENTEROLOGY (2008)
Is There a Meaningful Serum Hepatitis B Virus DNA Cutoff Level for Therapeutic Decisions in Hepatitis B e Antigen-Negative Chronic Hepatitis B Virus Infection?
George V. Papatheodoridis et al.
HEPATOLOGY (2008)
Serum aminotransferase activity and mortality risk in a United States community
Tae Hoon Lee et al.
HEPATOLOGY (2008)
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
W. Ray Kim et al.
HEPATOLOGY (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection
G. V. Papatheodoridis et al.
JOURNAL OF VIRAL HEPATITIS (2008)
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
J. Y. Park et al.
JOURNAL OF VIRAL HEPATITIS (2008)
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B
Jordan J. Feld et al.
HEPATOLOGY (2007)
Risk and predictors of mortality associated with chronic hepatitis B infection
Uchenna H. Iloeje et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
Chih-Lin Lin et al.
HEPATOLOGY (2007)
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
Chia-Ming Chu et al.
HEPATOLOGY (2007)
Long-term outcome of chronic hepatitis B based on histological grade and stage
Byung Kyu Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase
Kenji Ikeda et al.
AMERICAN JOURNAL OF MEDICINE (2006)
PGC-1α controls hepatitis B virus through nutritional signals
Amir Shlomai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study
R Kariv et al.
LIVER INTERNATIONAL (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
MF Yuen et al.
GUT (2005)
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
GH Zacharakis et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
HC Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
CM Chu et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B
RP Perrillo et al.
HEPATOLOGY (2002)
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
YS Hsu et al.
HEPATOLOGY (2002)
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
M Martinot-Peignoux et al.
JOURNAL OF HEPATOLOGY (2002)
分享论文
